Clinical Ink is a global clinical trial technology company that is transforming the clinical trial experience. By connecting clients to a proven and future-built eSource platform that accelerates time to value while delivering scientific results that matter, we’re proud to be advancing the business model responsible for bringing new treatments to market.
Clinical Ink
Latest Content
Handling complexity in GI trials — a purpose-built eCOA/ePRO solution
Paid for and content provided by Clinical Ink
The accelerating complexity of gastroenterology protocols has exceeded the capacity of most electronic clinical outcome assessments (eCOAs) to adapt.
Accelerating Database Lock: Adaptive Design & Remote Monitoring
Paid for and content provided by Clinical Ink
CASE STUDY: A pharmaceutical company conducting a Phase III study of an investigational ointment required an eSource solution that could support remote monitoring, video uploads, and image capture and provide push-button randomization.
SUCCEED WITH BYOD FOR ePRO IN ANY PHASE OF CLINICAL RESEARCH
Paid for and content provided by Clinical Ink
As more and more people own smart phones, bring your own device (BYOD) patient data collection often makes sense. What are the risks and opportunities presented by such a strategy?
Related Resources
Virtual Trials: Trust in Experience, Trust in Lunexis™
From Infectious Disease to BYOD, We Set the Bar for Virtual Trials
Introduction to eLAS®
Clinical Ink has developed a unique offering — the electronic Lupus Assessment Suite (eLAS®) to address fundamental challenges impacting systemic lupus erythematosus (SLE) studies and the integrity of the study endpoints.
Deploy Configurable, Mixed-Modality ePRO Solutions, Fast
Real-Time, Integrated Data Capture With Unprecedented Freedom of Choice